ofloxacin has been researched along with Sexually Transmitted Diseases in 16 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Sexually Transmitted Diseases: Diseases due to or propagated by sexual contact.
Excerpt | Relevance | Reference |
---|---|---|
"Efficacy and safety of ofloxacin (OFLX), a new quinolone antibacterial agent, were investigated in cases of sexually transmitted male urethritis and cervicitis." | 9.06 | [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]. ( Aso, Y; Higashihara, E; Hirose, T; Kishi, H; Kiyota, H; Kumamoto, Y; Machida, T; Okazaki, T; Sakai, S; Tsunekawa, T, 1988) |
" trachomatis urethritis were treated for five days with 2 X 200 mg ofloxacin." | 9.06 | Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. ( Bischoff, W, 1986) |
"Uncomplicated pelvic inflammatory disease (PID) is a common disease caused by numerous pathogens: sexually transmitted infections (such as Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium), anaerobes, and other organisms from the vaginal flora." | 6.74 | Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study. ( Judlin, P; Thiebaugeorges, O, 2009) |
"Sexually transmitted diseases are an important cause of morbidity in women." | 6.38 | The clinical experience with ofloxacin in the treatment of sexually transmitted diseases. ( Corrado, ML, 1991) |
"Efficacy and safety of ofloxacin (OFLX), a new quinolone antibacterial agent, were investigated in cases of sexually transmitted male urethritis and cervicitis." | 5.06 | [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]. ( Aso, Y; Higashihara, E; Hirose, T; Kishi, H; Kiyota, H; Kumamoto, Y; Machida, T; Okazaki, T; Sakai, S; Tsunekawa, T, 1988) |
"Experience with ofloxacin in the United States in the treatment of sexually transmitted diseases is reviewed." | 5.06 | Clinical experience with ofloxacin in sexually transmitted disease. ( Beals, BS; Judson, FN; Tack, KJ, 1986) |
" trachomatis urethritis were treated for five days with 2 X 200 mg ofloxacin." | 5.06 | Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. ( Bischoff, W, 1986) |
"Uncomplicated pelvic inflammatory disease (PID) is a common disease caused by numerous pathogens: sexually transmitted infections (such as Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium), anaerobes, and other organisms from the vaginal flora." | 2.74 | Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study. ( Judlin, P; Thiebaugeorges, O, 2009) |
"Gonorrhea, trichomoniasis, chlamydiosis and Ureaplasma infection were detected in 60, 31." | 2.67 | [Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases]. ( Bakalova, LA; Bednova, VN; Bugrov, AV; Kisina, VI; Navolotskaia, TI; Vakhnina, TE, 1992) |
"Sexually transmitted diseases are an important cause of morbidity in women." | 2.38 | The clinical experience with ofloxacin in the treatment of sexually transmitted diseases. ( Corrado, ML, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (43.75) | 18.7374 |
1990's | 5 (31.25) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Woods, JL | 1 |
Scurlock, AM | 1 |
Hensel, DJ | 1 |
Haggerty, CL | 1 |
Ness, RB | 1 |
Judlin, P | 1 |
Thiebaugeorges, O | 1 |
Hooper, DC | 1 |
Bednova, VN | 1 |
Bakalova, LA | 1 |
Bugrov, AV | 1 |
Navolotskaia, TI | 1 |
Kisina, VI | 1 |
Vakhnina, TE | 1 |
Nakata, S | 1 |
Miki, M | 1 |
Okabe, K | 1 |
Mashimo, T | 1 |
Kobayashi, M | 1 |
Yamanaka, H | 1 |
Takahashi, O | 1 |
Onuki, T | 1 |
Corrado, ML | 1 |
Waldvogel, FA | 1 |
Neu, HC | 1 |
Kumamoto, Y | 1 |
Sakai, S | 1 |
Hirose, T | 1 |
Tsunekawa, T | 1 |
Machida, T | 1 |
Kiyota, H | 1 |
Okazaki, T | 1 |
Kishi, H | 1 |
Higashihara, E | 1 |
Aso, Y | 1 |
Hartinger, A | 1 |
Korting, HC | 1 |
Neubert, U | 1 |
Blaufuss, H | 1 |
Fransen, L | 1 |
Avonts, D | 1 |
Piot, P | 1 |
Judson, FN | 1 |
Beals, BS | 1 |
Tack, KJ | 1 |
Bischoff, W | 1 |
3 reviews available for ofloxacin and Sexually Transmitted Diseases
Article | Year |
---|---|
Diagnosis and treatment of pelvic inflammatory disease.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Female; Humans; Infertility, Fema | 2008 |
New uses for new and old quinolones and the challenge of resistance.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; M | 2000 |
The clinical experience with ofloxacin in the treatment of sexually transmitted diseases.
Topics: Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Ofloxacin; Pelvic Inflammato | 1991 |
6 trials available for ofloxacin and Sexually Transmitted Diseases
Article | Year |
---|---|
Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Female; Humans; Levofloxacin; Metronidazole; Ofl | 2009 |
[Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
Topics: Chlamydia Infections; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female | 1992 |
[Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis].
Topics: Adult; Chlamydia Infections; Chlamydia trachomatis; Drug Evaluation; Female; Gonorrhea; Humans; Male | 1988 |
Treatment of genital chlamydial infection with ofloxacin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; | 1986 |
Clinical experience with ofloxacin in sexually transmitted disease.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Clinical Trials as Topic; Double | 1986 |
Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Clinical Trials as Topic; | 1986 |
7 other studies available for ofloxacin and Sexually Transmitted Diseases
Article | Year |
---|---|
Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
Topics: Adolescent; Anti-Bacterial Agents; Arkansas; Ceftriaxone; Centers for Disease Control and Prevention | 2013 |
National guideline for the management of epididymo-orchitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Epididymitis; | 1999 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; | 1999 |
[Clinical analysis of male urethritis].
Topics: Adolescent; Adult; Child; Gonorrhea; Humans; Japan; Lymphogranuloma Venereum; Male; Middle Aged; Min | 1991 |
Clinical role of the quinolones today and in the future.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Protocols; Forecasting; Humans; | 1989 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthy | 1987 |
[In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Topics: Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Female | 1988 |